The specialists value the use of a technique called LIPOSCALE that analyzes the size and number of lipoproteins in cardiovascular screening.
“Until now, we did not have in the clinic of any tool, of any test or advanced test of determination of lipoproteínas; But recently a technology has been developed in Spain based on magnetic resonance spectroscopy of two dimensions that allows to analyze, through a relatively simple and exportable procedure to the clinic, the patient’s lipoprotein map, it is to be hoped that it will soon be available to clinicians”, said Dr. Jacinto Fernández Pardo, head of the Arterial Hypertension and Lipids Unit of the General University Hospital Reina Sofía of Murcia, during his speech at a panel on ‘Importance Of the size of lipoproteins in cardiovascular screening: from theory to clinical practice ‘, which took place during the XXIX National Congress of the Spanish Society of Arteriosclerosis (SEA) held in Granada last May.
